M. Ryba

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

M. Vervloet, D. Fouque, P. Ureña, 2013, Clinical kidney journal.

"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study.

M. Vervloet, D. Fouque, H. Saha, 2010, Clinical nephrology.

Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.

D. Fouque, S. Jacobson, F. Pétavy, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.

M. Vervloet, D. Fouque, H. Saha, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.

S. Kuriyakose, S. Houard, C. Tielemans, 2010, Kidney international.

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

M. Jadoul, G. Verpooten, S. Kuriyakose, 2011, Vaccine.

Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients

J. Hajny, O. Viklicky, J. Hubacek, 2007, Clinical chemistry and laboratory medicine.

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.

S. Houard, C. Tielemans, P. Vörös, 2010, Kidney international.

Anti-HBs antibody persistence following primary vaccination with an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency

M. Jadoul, P. Peeters, S. Houard, 2011, Human vaccines.